Breaking News Instant updates and real-time market news.

GBNXF

Gibson Energy

$0.00 /

+ (+0.00%)

12:35
08/06/20
08/06
12:35
08/06/20
12:35

Gibson Energy price target raised to C$25 from C$24 at CIBC

CIBC analyst Robert Catellier raised the firm's price target on Gibson Energy to C$25 from C$24 and keeps a Neutral rating on the shares.

GBNXF Gibson Energy
$0.00 /

+ (+0.00%)

08/06/20 RBC Capital
Gibson Energy price target raised to C$27 from C$25 at RBC Capital
08/06/20 Scotiabank
Gibson Energy price target raised to C$26 from C$23 at Scotiabank
08/06/20 TD Securities
Gibson Energy price target raised to C$24 from C$22 at TD Securities
08/05/20 BMO Capital
Gibson Energy price target raised to C$26 from C$23 at BMO Capital

TODAY'S FREE FLY STORIES

Recommendations
Protagonist Therapeutics price target raised to $33 from $28 at H.C. Wainwright » 06:22
09/18/20
09/18
06:22
09/18/20
06:22
PTGX

Protagonist Therapeutics

$21.23 /

+0.06 (+0.28%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

07/15/20 Jefferies
Protagonist Therapeutics initiated with a Buy at Jefferies
05/18/20 H.C. Wainwright
Protagonist Therapeutics price target raised to $28 from $23 at H.C. Wainwright
05/11/20 Nomura Instinet
Protagonist Therapeutics price target raised to $33 from $29 at Nomura Instinet
04/30/20 Nomura Instinet
Protagonist shares offer 'asymmetric potential upside,' says Nomura Instinet
PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

  • 12
    May
PTGX Protagonist Therapeutics
$21.23 /

+0.06 (+0.28%)

Recommendations
Gilead price target raised to $86 from $82 at RBC Capital » 06:21
09/18/20
09/18
06:21
09/18/20
06:21
GILD

Gilead

$65.02 /

-0.62 (-0.94%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
09/15/20 Maxim
Gilead upgraded to Buy from Hold at Maxim
09/15/20 RBC Capital
Gilead price target lowered to $82 from $84 at RBC Capital
GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

GILD Gilead
$65.02 /

-0.62 (-0.94%)

Recommendations
Arena Pharmaceuticals price target raised to $120 from $83 at Citi » 06:20
09/18/20
09/18
06:20
09/18/20
06:20
ARNA

Arena Pharmaceuticals

$70.48 /

+0.57 (+0.82%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

09/14/20 JPMorgan
Arena Pharmaceuticals resumed with an Overweight at JPMorgan
08/17/20 Guggenheim
Arena Pharmaceuticals price target raised to $115 from $95 at Guggenheim
08/06/20 SVB Leerink
Arena Pharmaceuticals price target raised to $91 from $73 at SVB Leerink
08/06/20 Wells Fargo
Arena Pharmaceuticals price target raised to $78 from $60 at Wells Fargo
ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

  • 28
    May
ARNA Arena Pharmaceuticals
$70.48 /

+0.57 (+0.82%)

Periodicals
UPS to make buyout offers to certain management staffers, WSJ reports » 06:19
09/18/20
09/18
06:19
09/18/20
06:19
UPS

UPS

$159.75 /

-0.105 (-0.07%)

UPS is looking to cut…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$159.75 /

-0.105 (-0.07%)

UPS UPS
$159.75 /

-0.105 (-0.07%)

09/17/20 Deutsche Bank
FedEx price target raised to $243 from $150 at Deutsche Bank
09/03/20
Fly Intel: Top five analyst downgrades
09/03/20 Berenberg
Berenberg sees 'parcel pair trade,' raises FedEx to Buy and cuts UPS to Sell
09/03/20 Berenberg
UPS downgraded to Sell from Hold at Berenberg
UPS UPS
$159.75 /

-0.105 (-0.07%)

UPS UPS
$159.75 /

-0.105 (-0.07%)

UPS UPS
$159.75 /

-0.105 (-0.07%)

UPS UPS
$159.75 /

-0.105 (-0.07%)

Initiation
Utz Brands initiated with a Buy at Citi » 06:18
09/18/20
09/18
06:18
09/18/20
06:18
UTZ

Utz Brands

$17.81 /

-0.035 (-0.20%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UTZ Utz Brands
$17.81 /

-0.035 (-0.20%)

UTZ Utz Brands
$17.81 /

-0.035 (-0.20%)

09/16/20
Fly Intel: Top five analyst initiations
09/16/20 Piper Sandler
Utz Brands initiated with a Neutral at Piper Sandler
Syndicate
OneWater Marine 3.171M share Secondary priced at $20.00 » 06:18
09/18/20
09/18
06:18
09/18/20
06:18
ONEW

OneWater Marine

$22.23 /

+0.93 (+4.37%)

Truist, Baird and Raymond…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEW OneWater Marine
$22.23 /

+0.93 (+4.37%)

ONEW OneWater Marine
$22.23 /

+0.93 (+4.37%)

06/16/20 SunTrust
SunTrust raises 2020 marine retail volume forecast to down 5% to flat
06/04/20 Raymond James
OneWater Marine price target raised to $20 from $17.50 at Raymond James
05/08/20 SunTrust
OneWater Marine price target raised to $16 from $7 at SunTrust
04/06/20 Baird
OneWater Marine downgraded to Neutral at Baird
ONEW OneWater Marine
$22.23 /

+0.93 (+4.37%)

  • 18
    Sep
  • 07
    Feb
ONEW OneWater Marine
$22.23 /

+0.93 (+4.37%)

Syndicate
COMPASS Pathways 7.5M share IPO priced at $17.00 » 06:17
09/18/20
09/18
06:17
09/18/20
06:17
CMPS

COMPASS Pathways

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 18
    Sep
Hot Stocks
Moxian regains Nasdaq compliance » 06:17
09/18/20
09/18
06:17
09/18/20
06:17
MOXC

Moxian

$2.25 /

+0.09 (+4.17%)

Moxian announces it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOXC Moxian
$2.25 /

+0.09 (+4.17%)

MOXC Moxian
$2.25 /

+0.09 (+4.17%)

Recommendations
Citi boosts Jabil target to $45 from $40, adds 'Catalyst Watch' » 06:16
09/18/20
09/18
06:16
09/18/20
06:16
JBL

Jabil

$32.97 /

+0.24 (+0.73%)

, AAPL

Apple

$110.35 /

-1.72 (-1.53%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBL Jabil
$32.97 /

+0.24 (+0.73%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

JBL Jabil
$32.97 /

+0.24 (+0.73%)

07/17/20 JPMorgan
Jabil price target raised to $43 from $40 at JPMorgan
07/16/20
Fly Intel: Top five analyst upgrades
07/15/20 Goldman Sachs
Jabil upgraded to Buy from Neutral at Goldman Sachs
06/22/20 RBC Capital
Jabil price target raised to $35 from $30 at RBC Capital
AAPL Apple
$110.35 /

-1.72 (-1.53%)

09/17/20 BWS Financial
AXT rumors of Apple win highlight value, says BWS Financial
09/17/20 Jefferies
Apple price target raised to $135 from $116.25 at Jefferies
09/16/20 B. Riley FBR
AXT Inc. shares may be overreacting to Apple Watch 6 news, says B. Riley FBR
09/16/20 Wedbush
Focus remains Apple iPhone 12 5G 'supercycle,' says Wedbush
JBL Jabil
$32.97 /

+0.24 (+0.73%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

Periodicals
AMD to take 20% share of notebook processor market in 2020, DigiTimes reports » 06:16
09/18/20
09/18
06:16
09/18/20
06:16
AMD

AMD

$76.55 /

-0.1 (-0.13%)

AMD is expected to see…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMD AMD
$76.55 /

-0.1 (-0.13%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

09/09/20 Lynx
Lynx raises outlook for AMD to a $110B market cap, price expectation in the $90s
09/02/20 Wells Fargo
New processors should make Intel more competitive with AMD, says Wells Fargo
09/02/20 Goldman Sachs
Nvidia price target raised to $585 from $528 at Goldman Sachs
09/01/20 Goldman Sachs
AMD price target raised to $84 from $50 at Goldman Sachs
AMD AMD
$76.55 /

-0.1 (-0.13%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

Periodicals
Two senators demand Amazon stop spying on workers, Business Insider reports » 06:14
09/18/20
09/18
06:14
09/18/20
06:14
AMZN

Amazon.com

$3,010.11 /

-67.03 (-2.18%)

Senators Ron Wyden and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

09/16/20 Morgan Stanley
FedEx price target raised to $250 from $110 at Morgan Stanley
09/08/20 Goldman Sachs
Goldman sticks with Sell on Apple despite 71% rally since downgrade
09/03/20 Baird
Amazon working to better handle unprecedented seasonal Q4 demand, says Baird
09/03/20 Baird
Amazon.com meetings reinforce top pick status, says Baird
AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

AMZN Amazon.com
$3,010.11 /

-67.03 (-2.18%)

Recommendations
Azure Power price target raised to $38 from $28 at JMP Securities » 06:14
09/18/20
09/18
06:14
09/18/20
06:14
AZRE

Azure Power

$31.82 /

+0.72 (+2.32%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZRE Azure Power
$31.82 /

+0.72 (+2.32%)

AZRE Azure Power
$31.82 /

+0.72 (+2.32%)

08/17/20 Barclays
Azure Power price target raised to $27 from $22 at Barclays
06/16/20 Barclays
Azure Power price target raised to $22 from $19 at Barclays
06/16/20 JMP Securities
Azure Power price target lowered to $28 from $30 at JMP Securities
11/25/19
Fly Intel: Top five analyst initiations
AZRE Azure Power
$31.82 /

+0.72 (+2.32%)

Downgrade
Mirati Therapeutics downgraded to Neutral from Buy at Citi » 06:14
09/18/20
09/18
06:14
09/18/20
06:14
MRTX

Mirati Therapeutics

$161.86 /

-0.89 (-0.55%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$161.86 /

-0.89 (-0.55%)

MRTX Mirati Therapeutics
$161.86 /

-0.89 (-0.55%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 H.C. Wainwright
Mirati Therapeutics price target raised to $185 from $163 at H.C. Wainwright
08/10/20 Oppenheimer
Mirati Therapeutics price target raised to $133 from $105 at Oppenheimer
08/07/20 Barclays
Mirati Therapeutics price target raised to $143 from $123 at Barclays
MRTX Mirati Therapeutics
$161.86 /

-0.89 (-0.55%)

  • 10
    Jan
MRTX Mirati Therapeutics
$161.86 /

-0.89 (-0.55%)

Downgrade
Aimco downgraded to Sell from Neutral at Citi » 06:13
09/18/20
09/18
06:13
09/18/20
06:13
AIV

Aimco

$36.36 /

-0.825 (-2.22%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIV Aimco
$36.36 /

-0.825 (-2.22%)

AIV Aimco
$36.36 /

-0.825 (-2.22%)

09/14/20 BofA
Aimco upgraded to Neutral at BofA after split announcement
09/14/20 BofA
Aimco upgraded to Neutral from Underperform at BofA
09/09/20
Fly Intel: Top five analyst downgrades
09/09/20 Goldman Sachs
Aimco downgraded to Neutral from Buy at Goldman Sachs
AIV Aimco
$36.36 /

-0.825 (-2.22%)

AIV Aimco
$36.36 /

-0.825 (-2.22%)

Syndicate
Essential Properties Realty Trust 8M share Spot Secondary priced at $19.00 » 06:12
09/18/20
09/18
06:12
09/18/20
06:12
EPRT

Essential Properties Realty Trust

$19.84 /

-0.28 (-1.39%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPRT Essential Properties Realty Trust
$19.84 /

-0.28 (-1.39%)

EPRT Essential Properties Realty Trust
$19.84 /

-0.28 (-1.39%)

07/02/20 Citi
Essential Properties Realty Trust price target raised to $15 from $10 at Citi
06/08/20 Evercore ISI
Essential Properties upgraded to Outperform from In Line at Evercore ISI
04/16/20 Scotiabank
Essential Properties downgraded to Sector Perform from Outperform at Scotiabank
04/07/20 Citi
Essential Properties Realty Trust price target lowered to $10 from $26 at Citi
EPRT Essential Properties Realty Trust
$19.84 /

-0.28 (-1.39%)

  • 18
    Sep
  • 10
    Jan
Initiation
Intellia Therapeutics initiated with a Buy at Goldman Sachs » 06:11
09/18/20
09/18
06:11
09/18/20
06:11
NTLA

Intellia Therapeutics

$22.44 /

-0.52 (-2.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

08/20/20 Chardan
Intellia Therapeutics nearing an inflection point, says Chardan
06/01/20 Wedbush
Intellia Therapeutics price target raised to $20 from $16 at Wedbush
02/28/20 Oppenheimer
Intellia making progress in in-vivo editing, says Oppenheimer
02/14/20 Wedbush
Intellia Therapeutics downgraded to Neutral from Outperform at Wedbush
NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

  • 03
    Jun
NTLA Intellia Therapeutics
$22.44 /

-0.52 (-2.26%)

Periodicals
GNC Holdings wins court approval for sale to China's Harbin, WSJ reports » 06:10
09/18/20
09/18
06:10
09/18/20
06:10
GNC

GNC Holdings

$0.00 /

+ (+0.00%)

GNC has won court…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNC GNC Holdings
$0.00 /

+ (+0.00%)

GNC GNC Holdings
$0.00 /

+ (+0.00%)

03/17/20 Jefferies
Jefferies cuts GNC Holdings to Underperform on risk from closures and debt
03/17/20 Jefferies
GNC Holdings downgraded to Underperform from Hold at Jefferies
GNC GNC Holdings
$0.00 /

+ (+0.00%)

GNC GNC Holdings
$0.00 /

+ (+0.00%)

GNC GNC Holdings
$0.00 /

+ (+0.00%)

Recommendations
Cheesecake Factory price target raised to $38 from $30 at Piper Sandler » 06:08
09/18/20
09/18
06:08
09/18/20
06:08
CAKE

Cheesecake Factory

$29.32 /

-1.725 (-5.56%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

08/03/20 BofA
Cheesecake Factory downgraded to Underperform from Neutral at BofA
07/09/20 Credit Suisse
Cheesecake Factory initiated with a Neutral at Credit Suisse
07/01/20 Gordon Haskett
Cheesecake Factory downgraded to Hold as reopenings pause at Gordon Haskett
07/01/20 Gordon Haskett
Cheesecake Factory downgraded to Hold from Buy at Gordon Haskett
CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

CAKE Cheesecake Factory
$29.32 /

-1.725 (-5.56%)

Initiation
Intuit initiated with an Overweight at Piper Sandler » 06:07
09/18/20
09/18
06:07
09/18/20
06:07
INTU

Intuit

$307.15 /

-6.325 (-2.02%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

08/27/20 Argus
Intuit price target raised to $400 from $325 at Argus
08/26/20 RBC Capital
Intuit price target raised to $405 from $315 at RBC Capital
08/26/20 Oppenheimer
Intuit price target raised to $355 from $308 at Oppenheimer
08/26/20 Guggenheim
Intuit price target raised to $395 from $320 at Guggenheim
INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

Hot Stocks
PG&E CFO Jason Wells resigns to become CFO of another utility » 06:07
09/18/20
09/18
06:07
09/18/20
06:07
PCG

PG&E

$9.79 /

-0.02 (-0.20%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

08/03/20 Mizuho
PG&E price target raised to $14.50 from $13.50 at Mizuho
07/28/20 Citi
PG&E shares look inexpensive into wildfire season, says Citi
07/26/20 Goldman Sachs
PG&E resumed with a Buy at Goldman Sachs
07/09/20 Mizuho
PG&E trading at 56% price-to-earnings discount, says Mizuho
PCG PG&E
$9.79 /

-0.02 (-0.20%)

  • 26
    Jun
PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

Initiation
BioLife Solutions initiated with an Outperform at Cowen » 06:06
09/18/20
09/18
06:06
09/18/20
06:06
BLFS

BioLife Solutions

$25.38 /

-0.42 (-1.63%)

Cowen analyst Chris Lin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

08/11/20 Benchmark
BioLife Solutions downgraded at Benchmark as shares reach price target
08/11/20 Benchmark
BioLife Solutions downgraded to Hold from Buy at Benchmark
07/10/20 B. Riley FBR
BioLife Solutions price target raised to $25.50 from $20 at B. Riley FBR
07/08/20 Northland
BioLife Solutions price target raised to $28 from $24 at Northland
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

  • 02
    Jul
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

Periodicals
SoftBank selling Brightstar to private equity firm, WSJ reports » 06:05
09/18/20
09/18
06:05
09/18/20
06:05
SFTBY

SoftBank

$0.00 /

+ (+0.00%)

SoftBank is selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/15/20 Oppenheimer
Nvidia's acquisition of ARM strengthens AI hand, says Oppenheimer
09/14/20 Deutsche Bank
ARM customers could push back on Nvidia deal, says Deutsche Bank
09/14/20 RBC Capital
RBC Capital sees ARM Holdings deal as positive for Nvidia, negative for Intel
SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

Hot Stocks
Power REIT acquires Maine property for cannabis processing » 06:05
09/18/20
09/18
06:05
09/18/20
06:05
PW

Power REIT

$17.91 /

-1.32 (-6.86%)

Power REIT announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PW Power REIT
$17.91 /

-1.32 (-6.86%)

Initiation
Epiroc initiated with a Buy at Berenberg » 06:03
09/18/20
09/18
06:03
09/18/20
06:03
EPOKY

Epiroc

$0.00 /

+ (+0.00%)

Berenberg analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPOKY Epiroc
$0.00 /

+ (+0.00%)

07/24/20 JPMorgan
Epiroc price target raised to SEK 115 from SEK 105 at JPMorgan
07/24/20 Deutsche Bank
Epiroc price target raised to SEK 120 from SEK 105 at Deutsche Bank
07/24/20 Credit Suisse
Epiroc price target raised to SEK 105 from SEK 88 at Credit Suisse
07/24/20 UBS
UBS backs Buy on Epiroc after Q2 results
Hot Stocks
Incyte says retifanlimab 'generally well-tolerated' in Phase 2 trial » 06:02
09/18/20
09/18
06:02
09/18/20
06:02
INCY

Incyte

$90.32 /

+0.39 (+0.43%)

Incyte announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.